GOAL.MD Tirzepatide Review: Cost, an Unverified Founder Claim & Honest Verdict (2026)

Before anything else: some prior research claims GOAL.MD's co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a reinstated license revocation. This is a serious allegation about a real, named individual, and this review's attempt to independently verify it this check was limited — the site itself is a JavaScript-rendered shell that doesn't name its physicians in the static content, and web search capacity for this session was already exhausted before this claim could be checked directly.

A serious claim this review could not independently verify

GOAL.MD's co-founder and chief physician is alleged to have a 2016 federal guilty plea for distributing misbranded HGH and a license revocation that was later reinstated. This review attempted to confirm this directly but could not this check — the live site doesn't name its physicians in the content that's retrievable, and this session's search capacity was exhausted before the claim could be independently checked against court or licensing records. This is reported honestly as an unconfirmed claim from prior research, not as something this review verified itself. If this matters to your decision, look up the specific physician's name directly on GOAL.MD's site and search state medical board and federal court records yourself.

What GOAL.MD is

GOAL.MD is a St. Louis-based telehealth platform, offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. It operates across all 50 states.

What GOAL.MD costs

Tirzepatide starts at $249/month at the starting dose, with transparent dose-tiered pricing published for brand pens. GOAL.MD's standout structural feature is a manual-renewal model — no auto-billing, meaning you actively re-up rather than being charged automatically.

The brand-vs-compounded question

GOAL.MD offers both compounded semaglutide and brand-name bridges. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

GOAL.MD's real strengths is a genuinely manual-renewal billing model with no surprise auto-charges, LegitScript certification, a free nutrition coach, and a BBB A+ rating since 2021. The trade-offs are significant: this review found no named compounding pharmacy partner, no URAC or PCAB pharmacy accreditation, and — most importantly — a serious unverified claim about the chief physician's legal history that this review could not independently confirm or refute this check. As with any GLP-1 program, and especially one with an unresolved claim like this attached to it, do your own research on the specific physician named on the site before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

GOAL.MD's manual-renewal billing and BBB A+ rating are genuine positives but this review could not verify or refute a serious claim about its chief physician's legal history — do your own direct research on the named physician before committing. For providers whose leadership credentials this site has independently confirmed as positive, compare DrBrainRx or Emerge Weight Loss. See our best tirzepatide providers ranking for the full field.